Nancy Bélanger

695 total citations
13 papers, 576 citations indexed

About

Nancy Bélanger is a scholar working on Neurology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Nancy Bélanger has authored 13 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 9 papers in Cellular and Molecular Neuroscience and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Nancy Bélanger's work include Parkinson's Disease Mechanisms and Treatments (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Neurological disorders and treatments (5 papers). Nancy Bélanger is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Neurological disorders and treatments (5 papers). Nancy Bélanger collaborates with scholars based in Canada and United States. Nancy Bélanger's co-authors include Paul J. Bédard, Laurent Grégoire, Abdallah Hadj Tahar, Thérèse Di Paolo, Leonard T. Meltzer, Marc Morissette, Pershia Samadi, Frédéric Calon, Mehdi Dridi and Stéphan Desrochers and has published in prestigious journals such as European Journal of Pharmacology, Experimental Neurology and Neurobiology of Aging.

In The Last Decade

Nancy Bélanger

13 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nancy Bélanger Canada	12	405	351	101	75	55	13	576
Wai Kin D. Ko France	12	329 0.8×	301 0.9×	178 1.8×	79 1.1×	50 0.9×	14	619
Elsa Y. Pioli France	16	562 1.4×	442 1.3×	222 2.2×	164 2.2×	48 0.9×	29	883
Elisabetta Tronci Italy	20	728 1.8×	658 1.9×	199 2.0×	112 1.5×	130 2.4×	32	1.0k
Angus Nisbet United Kingdom	10	407 1.0×	236 0.7×	276 2.7×	44 0.6×	16 0.3×	16	692
Kevin Chen United States	10	267 0.7×	157 0.4×	224 2.2×	35 0.5×	31 0.6×	13	570
S. P. Markey United States	8	285 0.7×	265 0.8×	98 1.0×	39 0.5×	14 0.3×	11	516
Isabel Espadas Spain	11	345 0.9×	172 0.5×	213 2.1×	92 1.2×	18 0.3×	16	610
Cristina Alcacer Sweden	8	625 1.5×	411 1.2×	229 2.3×	103 1.4×	10 0.2×	11	744
Pershia Samadi Canada	18	713 1.8×	582 1.7×	245 2.4×	103 1.4×	22 0.4×	28	996
Ning-Sheng Cai United States	15	485 1.2×	82 0.2×	415 4.1×	93 1.2×	48 0.9×	21	759

Countries citing papers authored by Nancy Bélanger

Since Specialization

Citations

This map shows the geographic impact of Nancy Bélanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Bélanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Bélanger more than expected).

Fields of papers citing papers by Nancy Bélanger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Bélanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Bélanger. The network helps show where Nancy Bélanger may publish in the future.

Co-authorship network of co-authors of Nancy Bélanger

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Bélanger. A scholar is included among the top collaborators of Nancy Bélanger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Bélanger. Nancy Bélanger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Estrada‐Camarena, Erika, et al.. (2010). Estradiol modulation of cortical, striatal and raphe nucleus 5-HT1A and 5-HT2A receptors of female hemiparkinsonian monkeys after long-term ovariectomy. Neuropharmacology. 60(4). 642–652. 26 indexed citations

Hodgson, Robert A., Paul J. Bédard, Geoffrey B. Varty, et al.. (2010). Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders. Experimental Neurology. 225(2). 384–390. 78 indexed citations

Morissette, Marc, Pershia Samadi, Abdallah Hadj Tahar, Nancy Bélanger, & Thérèse Di Paolo. (2009). Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 34(3). 446–454. 38 indexed citations

Samadi, Pershia, Marc Morissette, Frédéric Calon, et al.. (2007). Normalization of GABA_A receptor specific binding in the substantia nigra reticulata and the prevention of L‐dopa‐induced dyskinesias in MPTP parkinsonian monkeys. Synapse. 62(2). 101–109. 11 indexed citations

Samadi, Pershia, Laurent Grégoire, Marc Morissette, et al.. (2007). Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesias. Neuropharmacology. 54(2). 258–268. 45 indexed citations

Samadi, Pershia, Laurent Grégoire, Marc Morissette, et al.. (2007). mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys. Neurobiology of Aging. 29(7). 1040–1051. 104 indexed citations

Bélanger, Nancy, Laurent Grégoire, Paul J. Bédard, & Thérèse Di Paolo. (2005). DHEA improves symptomatic treatment of moderately and severely impaired MPTP monkeys. Neurobiology of Aging. 27(11). 1684–1693. 29 indexed citations

Tahar, Abdallah Hadj, et al.. (2004). Effect of a selective glutamate antagonist on l-dopa-induced dyskinesias in drug-naive parkinsonian monkeys. Neurobiology of Disease. 15(2). 171–176. 117 indexed citations

Blanchet, Pierre J., Frédéric Calon, Marc Morissette, et al.. (2004). Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms. Parkinsonism & Related Disorders. 10(5). 297–304. 47 indexed citations

10.

Bélanger, Nancy, Laurent Grégoire, Abdallah Hadj Tahar, & Paul J. Bédard. (2003). Chronic treatment with small doses of cabergoline prevents dopa‐induced dyskinesias in parkinsonian monkeys. Movement Disorders. 18(12). 1436–1441. 34 indexed citations

11.

Bélanger, Nancy, Laurent Grégoire, Paul J. Bédard, & Thérèse Di Paolo. (2003). Estradiol and Dehydroepiandrosterone Potentiate Levodopa-Induced Locomotor Activity in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Monkeys. Endocrine. 21(1). 97–102. 19 indexed citations

12.

Bélanger, Nancy & Stéphan Desrochers. (2001). Can 6‐month‐old infants process causality in different types of causal events?. British Journal of Developmental Psychology. 19(1). 11–21. 14 indexed citations

13.

Tahar, Abdallah Hadj, et al.. (2000). Antidyskinetic effect of JL-18, a clozapine analog, in parkinsonian monkeys. European Journal of Pharmacology. 399(2-3). 183–186. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact